Cargando…
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
Cardiovascular diseases, involving vasculopathy, cardiac dysfunction, or circulatory disturbance, have become the major cause of death globally and brought heavy social burdens. The complexity and diversity of the pathogenic factors add difficulties to diagnosis and treatment, as well as lead to poo...
Autores principales: | Zhang, Meng-Wan, Shen, Yun-Jie, Shi, Jing, Yu, Jian-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854547/ https://www.ncbi.nlm.nih.gov/pubmed/33553260 http://dx.doi.org/10.3389/fcvm.2020.610561 |
Ejemplares similares
-
miR-223: a key regulator of pulmonary inflammation
por: Shi, Mingyu, et al.
Publicado: (2023) -
Diagnostic value of cardiac miR-126-5p, miR-134-5p, and miR-499a-5p in coronary artery disease-induced sudden cardiac death
por: Li, Linfeng, et al.
Publicado: (2022) -
miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway
por: Valmiki, Swati, et al.
Publicado: (2020) -
LDL Receptor Pathway Regulation by miR-224 and miR-520d
por: Salerno, Alessandro G., et al.
Publicado: (2020) -
MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability
por: Singh, Sandeep, et al.
Publicado: (2020)